Prostatitis is a common and unique syndrome and affects adult men of all ages (Mändar et al., 2020). The classification of National Institutes of Health (NIH) has been accepted internationally, including acute bacterial prostatitis (ABP), chronic bacterial prostatitis (CBP), chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and asymptomatic inflammatory prostatitis (AIP) (Khan et al., 2017).According to updated research, the prevalence of prostatitis is high and prone to recurrent attacks, which has a serious negative impact on patients' quality of life (QoL) (Schoeb et al., 2017;Zhu et al., 2017).Based on an epidemiological study of 12,743 participants, the prevalence of prostatitis-like symptoms in Chinese men is approximately 8.4% (Liang et al., 2009). Although prostatitis is not life-threatening, it is still a big conundrum for doctors and patients, especially CP/

No abstract